![]() ![]() Use a stoploss of 3.2 and if this stock hits its stoploss, then it can fall down till 3.04 UBX Unity Biotechnology is falling or rising NEWS fundamental reasons More announcements and NEWS UBX Unity Biotechnology, Inc. My analysis of Unity Biotechnology is bullish for shortterm, and stock might move up till 3.4 or till 3.6. This is a good sign, and the stock might keep rising and move higher! Stock of Unity Biotechnology (UBX) is trading above an important moving average line, and it has been above this line for quite some time now. It appears as if Unity Biotechnology UBX gave a large move recently. ![]() Look for opportunities to BUY or go LONG in Unity Biotechnology UBX at this time. This Q2 report starts with the company’s current. Technical analysis forecast of Unity Biotechnology Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Unity Biotechnology (NASDAQ: UBX) stock is surging higher on Friday following the release of its earnings report for the second quarter of 2022. ![]() is falling or rising UBX Unity Biotechnology is falling or rising technical reasons Volume 199,690 Market Cap 45.68 M Dividend 0.00 ( 0.00) Beta 0.69 Key Earnings Data Earnings ESP 0. UBX NEWS reasons for why stock price of Unity Biotechnology, Inc. Stock Activity Open 3.26 Day Low 3.11 Day High 3.35 52 Wk Low 1.46 52 Wk High 18.50 Avg. UBX NEWS why is Unity Biotechnology, Inc. Given the current short-term trend, the stock is expected to rise 47.62 during the next 3 months and, with a 90 probability hold a price between 3.67 and. ![]() The opinions expressed in this article are those of the writer, subject to the Publishing Guidelines. On the date of publication, William White did not hold (either directly or indirectly) any positions in the securities mentioned in this article. Fundamentals Market Capitalization, K 45,968 Shares Outstanding, K 14,365 Annual Sales, 240 K Annual Income, -59,930 K 60-Month Beta 0.69 Price/Sales 193.56 Price/Cash Flow N/A Price/Book 0.78 Trade UBX with: Price/Earnings ttm 0. Latest Press Release Published UNITY Biotechnology to Participate in the Cowen 43rd Annual Health Care Conference Earnings Per Share Estimated Reported 4Q21 1Q22 2Q22 3Q22 4Q22. So far 354,053 shares have traded compared to average volume of 182,324 shares. The stock has traded between 2.97 and 3.48 so far today. Read More: Penny Stocks - How to Profit Without Getting Scammed Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Unity Biotechnology Inc (UBX) stock is trading at 3.36 as of 2:25 PM on Wednesday, Jan 4, a rise of 0.39, or 13.34 from the previous closing price of 2.96. Discuss news and analysts price predictions with the investor community. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that ’s writers disclose this fact and warn readers of the risks. See UBX stock price and Buy/Sell Unity Biotechnology Inc. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |